Tag: BSE
Organon acquisition reports speculative – Sun Pharma
Sun Pharmaceutical Industries has called reports of its potential $10 billion acquisition of US-based Organon “speculative,” responding to a clarification request from the BSE....
Piramal Pharma issue gets SEBI green signal
Piramal pharma, the company that offers comprehensive pharmaceutical services to customers, covering various stages of the pharmaceutical product lifecycle, has received SEBI's go-ahead to...